ABBEYTOWN LIMITED

Company number 01200278 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Here is a comprehensive financial health assessment for Abbeytown Limited, applying a diagnostic approach to the company's financial vital signs.

1. Financial Health Score: B+

Explanation: The company is fundamentally robust with strong net assets and consistent profitability. However, it receives a B+ rather than an A due to a significant drop in cash reserves in the latest reporting period, indicating a temporary liquidity strain that needs monitoring. The patient is in great shape overall but is currently experiencing a mild cash flow cough.

2. Key Vital Signs

  • Net Assets (Financial Bone Density): £14.5 million (2021). The company's net worth has grown steadily from £13.2 million in 2018 to £14.5 million in 2021. This indicates a very strong structural foundation.
  • Profitability (Metabolic Rate): £667,894 (2021). The business generated a healthy profit, down slightly from £973,451 in 2020 but still showing robust operational health.
  • Cash Reserves (Hydration Levels): £212,696 (2021). This is a significant drop from £1,904,411 in 2020. The company is currently dehydrated in terms of immediate liquid assets.
  • Working Capital (Blood Flow): Net current assets of £13.8 million. While this looks excellent on the surface, it is heavily concentrated in stocks (£11.9 million) and debtors (£2.2 million), meaning the actual liquid "blood flow" is currently sluggish.
  • Liabilities (Cholesterol Levels): Total long-term debt stands at £4 million, down from £10.7 million in 2018. The company has done an excellent job of clearing its arteries of heavy debt over the past few years.

3. Diagnosis

Symptoms Analysis: The numbers reveal a business that is fundamentally sound but experiencing a temporary liquidity bottleneck. The most glaring symptom is the dramatic drop in cash from £1.9 million to £212k.

When we examine the balance sheet, we can see where the cash went. Trade debtors ballooned from £281,066 to £2,277,260—a massive increase. This suggests that the company has been waiting on payments from buyers or related parties. Additionally, the company paid out £500,000 in dividends during a year when cash reserves were falling.

The company holds nearly £12 million in stock, which for a property developer (SIC 41100) represents work-in-progress or completed building projects waiting to be sold.

Overall Condition: The patient is suffering from a mild case of "asset-rich, cash-poor" syndrome. The underlying business is generating profit and building equity, but cash is currently trapped in unpaid invoices and unsold properties.

4. Recommendations

  • Restore Cash Reserves (Rehydration Therapy): Prioritize the collection of the £2.2 million currently owed by debtors. Improving credit control processes will quickly restore healthy cash balances.
  • Monitor Stock Turnover (Digestive Health): With £11.9 million tied up in stocks, it is vital to ensure these properties are sold and converted to cash efficiently. If the property market slows, this stock could become a financial blockage.
  • Moderate Dividend Payouts (Dietary Restraint): While the company is profitable, paying out £500,000 in dividends while cash reserves dropped by over £1.6 million is aggressive. It would be prudent to pause or reduce dividend distributions until cash at bank is restored to safer levels (e.g., £1 million+).

Perspective: Financial Health Diagnostician · Model: glm-5.2 · Generated 9 October 2026